C12N 2502/45
Artificially induced pluripotent stem cells
C12N2502/45 (Artificially induced pluripotent stem cells) appears on 27 US grants and 70 published applications in this corpus.
Search patents in C12N- Granted patents
- 27
- Published applications
- 70
- Assignees
- 51
- Inventors
- 166
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 2 | 1 |
| 2016 | 1 | 3 |
| 2017 | 2 | 5 |
| 2018 | 1 | 3 |
| 2019 | 2 | 9 |
| 2020 | 4 | 8 |
| 2021 | 2 | 7 |
| 2022 | 4 | 5 |
| 2023 | 4 | 8 |
| 2024 | 0 | 6 |
| 2025 | 4 | 4 |
| 2026 | 1 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Development of amnion-like tissue from human pluripotent stem cells24 Feb 2026US 12,558,381 B2The Regents of the University of Michigan
- Methods for generating mimetic innate immune cells from pluripotent stem cells9 Sep 2025US 12,410,400 B2Agency for Science, Technology and Research
- Methods and systems for converting precursor cells into intestinal tissues through directed differentiation25 Mar 2025US 12,258,584 B2Children's Hospital Medical Center
- Methods of treating cancer using NK cells4 Mar 2025US 12,239,665 B2Honed Life Sciences, LLC
- Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip4 Mar 2025US 12,241,085 B2Cedars-Sinai Medical Center
- Composition for inducing direct differentiation of stem cells into corneal endothelial cells and method for inducing direct differentiation using same24 Sep 2026US 2026/0286295 A1The Asan Foundation
- Stimulatory antigen particles, methods of production, and methods of use thereof20 Aug 2026US 2026/0242731 A1Genentech, Inc.
- Adhesion molecule inhibition for stem cell therapies7 May 2026US 2026/0124246 A1Wisconsin Alumni Research Foundation
- Methods and systems for converting precursor cells into intestinal tissues through directed differentiation30 Apr 2026US 2026/0117190 A1Children's Hospital Medical Center
- Scalable Expansion of CD71+ Erythroid Progenitor Cells for Cell Therapy16 Apr 2026US 2026/0102431 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of Wnt-signalling pathway20US 9,394,522 B2Takara Bio Europe AB · 2016
- Methods and systems for converting precursor cells into intestinal tissues through directed differentiation18US 9,719,068 B2Children's Hospital Medical Center · 2017
- Methods and systems for converting precursor cells into intestinal tissues through directed differentiation13US 10,781,425 B2Children's Hospital Medical Center · 2020
- Methods for printing organs and organoids7US 10,513,691 B2Prellis Biologics, Inc. · 2019
- Providing iPSCs to a customer7US 9,213,999 B2Kyoto University · 2015